260366-86-7

Upstream product

• 260366-85-6 3-benzylamino-1-[2-(4-methoxy-phenyl)-ethyl]-1-aza-spiro[4.5]decan-8-one 
• 4746-97-8 cyclohexanedione monoethylene ketal 
• 55-81-2 4-Methoxyphenethylamine 
• 260366-92-5 (1,4-dioxa-spiro[4.5]dec-8-ylidene)-[2-(4-methoxy-phenyl)-ethyl]-amine 
• 260366-78-7 4-allyl-4-[2-(4-methoxyphenyl)ethylamino]cyclohexanone ethylene acetal 
• 260366-82-3 1-[2-(4-methoxyphenyl)ethyl]-1-azaspiro[4.5]decan-3,8-dione 8-monoethylene acetal 
• 260366-80-1 1-[2-(4-methoxyphenyl)ethyl]-3-iodo-1-azaspiro[4.5]decan-8-one ethylene acetal 
• 260366-84-5 3-benzylamino-1-[2-(4-methoxyphenyl)ethyl]-1-azaspiro[4.5]decan-8-one ethylene acetal 

Downstream Products

• 260366-87-8 trans-3-[N-benzyl-N-(tert-butoxycarbonyl)amino]-1-[2-(4-methoxyphenyl)-ethyl]-1-azaspiro[4.5]decan-8-ol 
• 260366-89-0 trans-3-[N-benzyl-N-(tert-butoxycarbonyl)amino]-1-[2-(4-methoxyphenyl)ethyl]-1-azaspiro[4.5]dec-8-yl dihydrogenphosphate 
• 260366-88-9 trans-3-[N-benzyl-N-(tert-butoxycarbonyl)amino]-1-[2-(4-methoxyphenyl)ethyl]-1-azaspiro[4.5]dec-8-yl dibenzyl phosphate 

Relevant academic research and scientific papers

Synthesis and biological evaluation of a conformationally free seco-analogue of the immunosuppressant FR901483

The synthesis of an azaspirocyclic analogue of FR901483, phosphate 2Figure 1Scheme 1Reagents and conditions: (i) 4-methoxyphenethylamine, molecular sieves; then allylmagnesium bromide, Et2O:CH2Cl2, 71%; (ii) I2,